The ferredoxin-cytochrome complex using heteronuclear nmr and docking simulation Deposition Author(s): Czjzek, M. , Guerlesquin, F. , Morelli, X. , Palma, P.N.
Date: 1999-12-08 Method: SOLUTION NMR, THEORETICAL MODEL Resolution: N.A. Organism(s): Desulfomicrobium Norvegicum , Desulfovibrio Vulgaris Sequences Data: 1DWL_A , 1DWL_B
Structural model of the [fe]-hydrogenase/cytochrome c553 complex combining nmr and soft-docking Deposition Author(s): Bornet, O. , Czjzek, M. , Fontecilla-Camps, J.C. , Guerlesquin, F. , Hatchikian, C.E. , Morelli, X. , Moura, J.J.G. , Palma, N.P.
Date: 2000-03-13 Method: SOLUTION NMR, THEORETICAL MODEL Resolution: N.A. Organism(s): Desulfovibrio Desulfuricans , Desulfovibrio Vulgaris Sequences Data: 1E08_A , 1E08_D , 1E08_E
Best model of the electron transfer complex between cytochrome c3 and [fe]-hydrogenase Deposition Author(s): Bornet, O. , Czjzek, M. , Dolla, A. , Elantak, L. , Guerlesquin, F. , Hatchikian, C. , Morelli, X.
Date: 2002-03-28 Method: SOLUTION NMR, THEORETICAL MODEL Resolution: N.A. Organism(s): Desulfovibrio Vulgaris Sequences Data: 1GX7_A , 1GX7_D , 1GX7_E
The response regulator tori belongs to a new family of atypical excisionase Deposition Author(s): Ansaldi, M. , Elantak, L. , Guerlesquin, F. , Mejean, V. , Morelli, X.
Date: 2005-03-16 Method: SOLUTION NMR Resolution: N.A. Organism(s): Escherichia Coli Sequences Data: 1Z4H_A
Solution structure of hndac : a thioredoxin-like [2fe-2s] ferredoxin involved in the nadp-reducing hydrogenase complex Deposition Author(s): Bornet, O. , Chetrit, B. , Dermoun, Z. , Guerlesquin, F. , Morelli, X. , Nouailler, M.
Date: 2005-08-29 Method: SOLUTION NMR Resolution: N.A. Organism(s): Desulfovibrio Fructosovorans Sequences Data: 2AUV_A
Crystal structure of type i cytochrome c3 from desulfovibrio africanus Deposition Author(s): Czjzek, M. , Guerlesquin, F. , Hatchikian, E.C. , Morelli, X. , Pieulle, L.
Date: 2005-04-27 Method: X-RAY DIFFRACTION Resolution: 1.68 Å Organism(s): Desulfovibrio Africanus Sequences Data: 2BQ4_A , 2BQ4_B
First domain of human bromodomain brd4 in complex with inhibitor n-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-1-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}piperidine-4-carboxamide Deposition Author(s): Betzi, S. , Morelli, X. , Raux, B. , Rebuffet, E.
Date: 2015-09-07 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Homo Sapiens Sequences Data: 5DLX_A
First domain of human bromodomain brd4 in complex with inhibitor 4-[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]-n-({1-[(3-methylphe methyl]piperidin-4-yl}methyl)butanamide Deposition Author(s): Betzi, S. , Morelli, X. , Raux, B. , Rebuffet, E.
Date: 2015-09-07 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Homo Sapiens Sequences Data: 5DLZ_A
First domain of human bromodomain brd4 in complex with inhibitor 3-butyl-8-(6-butyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-ylsulfanylmethyl)-7-ethyl-3,7-dihydropurine-2,6-dione Deposition Author(s): Betzi, S. , Morelli, X. , Priet, S. , Raux, B. , Rebuffet, E.
Date: 2015-10-27 Method: X-RAY DIFFRACTION Resolution: 2.21 Å Organism(s): Homo Sapiens Sequences Data: 5EGU_A , 5EGU_B , 5EGU_C , 5EGU_D
First domain of human bromodomain brd4 in complex with inhibitor 8-(5-amino-1h-[1,2,4]triazol-3-ylsulfanylmethyl)-3-(4-chlorobenzyl)-7-ethyl-3,7-dihydropurine-2,6-dione Deposition Author(s): Betzi, S. , Morelli, X. , Raux, B. , Rebuffet, E.
Date: 2015-10-29 Method: X-RAY DIFFRACTION Resolution: 1.05 Å Organism(s): Homo Sapiens Sequences Data: 5EI4_A